BOLT BIOTHERAPEUTICS INC (BOLT)

US0977021049 - Common Stock

0.76  -0.01 (-1.2%)

After market: 0.75 -0.01 (-1.32%)

Buy % Consensus

51

ChartMill assigns a Buy % Consensus number of 51% to BOLT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.27. This target is 67.76% above the current price.
BOLT was analyzed by 11 analysts. The buy percentage consensus is at 51. So analysts seem to be rather neutral about BOLT.
In the last month the buy percentage fell by 34 points. So the trust of analysts is decreasing.
BOLT was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 0.761.011.281.281.58 - 32.89% 67.76% 67.76% 107.24%
Up and Down Grades
Date Firm Action Rating
2024-05-15 Leerink Partners Downgrade Outperform -> Market Perform
2024-05-15 Jones Trading Downgrade Buy -> Hold
2024-05-15 Guggenheim Downgrade Buy -> Neutral
2024-05-15 Stifel Downgrade Buy -> Hold
2024-05-15 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-03-22 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-03 HC Wainwright & Co. Reiterate Buy
2023-06-05 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-26 HC Wainwright & Co. Reiterate Buy
2023-05-12 SVB Leerink Upgrade Market Perform -> Outperform
2023-05-12 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-30 HC Wainwright & Co. Reiterate Buy
2023-01-24 Morgan Stanley Maintains Equal-Weight
2022-10-04 HC Wainwright & Co. Initiate Buy
2022-08-11 SVB Leerink Downgrade Outperform -> Market Perform
2022-05-17 Morgan Stanley Maintains Equal-Weight
2022-01-06 Morgan Stanley Downgrade Overweight -> Equal-Weight
2021-11-10 SVB Leerink Maintains Outperform
2021-08-16 SVB Leerink Maintains Outperform
2021-05-17 SVB Leerink Maintains Outperform
2021-04-06 SVB Leerink Maintains Outperform
2021-03-02 Guggenheim Initiate Buy
2021-03-02 SVB Leerink Initiate Outperform
2021-03-02 Stifel Initiate Buy
2021-03-02 Morgan Stanley Initiate Overweight